nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
An Accessible and Unique Insight into Metastasis Mutational Content Through Whole-exome Sequencing of Circulating Tumor Cells in Metastatic Prostate Cancer
|
Faugeroux, Vincent |
|
|
3 |
4 |
p. 498-508 |
artikel |
2 |
Cabozantinib for Progressive Metastatic Castration-resistant Prostate Cancer Following Docetaxel: Combined Analysis of Two Phase 3 Trials
|
Sonpavde, Guru P. |
|
|
3 |
4 |
p. 540-543 |
artikel |
3 |
Comparative Effectiveness of Treatment Strategies for Squamous Cell Carcinoma of the Bladder
|
Stensland, Kristian D. |
|
|
3 |
4 |
p. 509-514 |
artikel |
4 |
Comparison of the Diagnostic Performance of Contrast-enhanced Ultrasound with That of Contrast-enhanced Computed Tomography and Contrast-enhanced Magnetic Resonance Imaging in the Evaluation of Renal Masses: A Systematic Review and Meta-analysis
|
Furrer, Marc A. |
|
|
3 |
4 |
p. 464-473 |
artikel |
5 |
Consulting “Dr. Google” for Prostate Cancer Treatment Options: A Contemporary Worldwide Trend Analysis
|
Cacciamani, Giovanni E. |
|
|
3 |
4 |
p. 481-488 |
artikel |
6 |
Contents
|
|
|
|
3 |
4 |
p. iii-vi |
artikel |
7 |
Correlations between Apparent Diffusion Coefficient and Gleason Score in Prostate Cancer: A Systematic Review
|
Surov, Alexey |
|
|
3 |
4 |
p. 489-497 |
artikel |
8 |
Defects in DNA Repair Genes Confer Improved Long-term Survival after Cisplatin-based Neoadjuvant Chemotherapy for Muscle-invasive Bladder Cancer
|
Miron, Benjamin |
|
|
3 |
4 |
p. 544-547 |
artikel |
9 |
Distribution of Molecular Subtypes in Muscle-invasive Bladder Cancer Is Driven by Sex-specific Differences
|
de Jong, Joep J. |
|
|
3 |
4 |
p. 420-423 |
artikel |
10 |
Editorial Board
|
|
|
|
3 |
4 |
p. i-ii |
artikel |
11 |
European Association of Urology Guidelines on Primary Urethral Carcinoma—2020 Update
|
Gakis, Georgios |
|
|
3 |
4 |
p. 424-432 |
artikel |
12 |
Key Perspectives on Managing Older Patients with Prostate Cancer: What We Know About the Fit and What We Need to Know About the Frail
|
Sridhar, Srikala S. |
|
|
3 |
4 |
p. 410-411 |
artikel |
13 |
Learning from Our Past Mistakes: A Call for Randomized Controlled Trials in Localized Renal Cell Carcinoma
|
Lawson, Keith A. |
|
|
3 |
4 |
p. 453-454 |
artikel |
14 |
Limitations of Available Studies Prevent Reliable Comparison Between Tumour Ablation and Partial Nephrectomy for Patients with Localised Renal Masses: A Systematic Review from the European Association of Urology Renal Cell Cancer Guideline Panel
|
Abu-Ghanem, Yasmin |
|
|
3 |
4 |
p. 433-452 |
artikel |
15 |
Management of Patients with Normal Cystoscopy but Positive Cytology or Urine Markers
|
Palou, Joan |
|
|
3 |
4 |
p. 548-554 |
artikel |
16 |
Multiparametric Magnetic Resonance Imaging-targeted Prostate Biopsy: A Plea for a Change in Terminology, and Beyond
|
Giannarini, Gianluca |
|
|
3 |
4 |
p. 395-396 |
artikel |
17 |
Pearls to Pivoting a Multidisciplinary Prostate Cancer Survivorship Program During the COVID-19 Pandemic
|
Flannigan, Ryan |
|
|
3 |
4 |
p. 397-399 |
artikel |
18 |
Radium-223 Within the Evolving Treatment Options for Metastatic Castration-resistant Prostate Cancer: Recommendations from a European Expert Working Group
|
O'Sullivan, Joe M. |
|
|
3 |
4 |
p. 455-463 |
artikel |
19 |
Rates and Predictors of Perioperative Complications in Cytoreductive Nephrectomy: Analysis of the Registry for Metastatic Renal Cell Carcinoma
|
Roussel, Eduard |
|
|
3 |
4 |
p. 523-529 |
artikel |
20 |
Re: Bimal Bhindi, Jeffrey Graham, J. Connor Wells, et al. Deferred Cytoreductive Nephrectomy in Patients with Newly Diagnosed Metastatic Renal Cell Carcinoma. Eur Urol. In press. https://doi.org/10.1016/j.eururo.2020.04.038
|
Mollica, Veronica |
|
|
3 |
4 |
p. 559-560 |
artikel |
21 |
Relative Contribution of Sampling and Grading to the Quality of Prostate Biopsy: Results from a Single High-volume Institution
|
Bravi, Carlo Andrea |
|
|
3 |
4 |
p. 474-480 |
artikel |
22 |
Re: Sungmin Woo, Valeria Panebianco, Yoshifumi Narumi, Diagnostic Performance of Vesical Imaging Reporting and Data System for the Prediction of Muscle-invasive Bladder Cancer: A Systematic Review and Meta-analysis. Eur Urol Oncol 2020;3:306–315
|
Glykas, Ioannis |
|
|
3 |
4 |
p. 555-556 |
artikel |
23 |
Re: Timothy J. Wilt, Tien N. Vo, Lisa Langsetmo, et al. Radical Prostatectomy or Observation for Clinically Localized Prostate Cancer: Extended Follow-up of the Prostate Cancer Intervention Versus Observation Trial (PIVOT). Eur Urol 2020;77:713–724
|
Rakic, Nikola |
|
|
3 |
4 |
p. 557-558 |
artikel |
24 |
Re: Toni K. Choueiri, Daniel Y.C. Heng, Jae Lyun Lee, et al. Efficacy of Savolitinib vs Sunitinib in Patients With MET-Driven Papillary Renal Cell Carcinoma: The SAVOIR Phase 3 Randomized Clinical Trial. JAMA Oncol. In press. https://doi.org/10.1001/jamaoncol.2020.2218
|
Mollica, Veronica |
|
|
3 |
4 |
p. 561-562 |
artikel |
25 |
Risk Assessment and Considerations for Proper Management of Elderly Men with Advanced Prostate Cancer: A Systematic Review
|
Shevach, Jeffrey W. |
|
|
3 |
4 |
p. 400-409 |
artikel |
26 |
Synchronous Versus Metachronous Metastatic Disease: Impact of Time to Metastasis on Patient Outcome—Results from the International Metastatic Renal Cell Carcinoma Database Consortium
|
Donskov, Frede |
|
|
3 |
4 |
p. 530-539 |
artikel |
27 |
The Automated Bone Scan Index as a Predictor of Response to Prostate Radiotherapy in Men with Newly Diagnosed Metastatic Prostate Cancer: An Exploratory Analysis of STAMPEDE’s “M1|RT Comparison”
|
Ali, Adnan |
|
|
3 |
4 |
p. 412-419 |
artikel |
28 |
The Cost to Medicare of Bladder Cancer Care
|
Sloan, Frank A. |
|
|
3 |
4 |
p. 515-522 |
artikel |